Abstract Patients with chronic renal insufficiency (CRI), also at its early stages, have an elevated risk of cardiovascular disease (CVD). Many well-established risk factors of CVD co-occur in CRI, e.g. dyslipidemia and hypertension. The present studies investigated the association between renal function and selected CVD risk factors. The fractional catabolic rate of low-density lipoprotein apolipoprotein B (LDL FCR) has previously been found to be reduced in patients with severe CRI or on dialysis. This study investigated the LDL FCR in 57 patients with moderate to severe CRI and not on dialysis. Although the mean LDL FCR was comparable between the CRI patients and healthy controls, among the renal patients the LDL FCR was correlated with...
Aim To investigate the association of parameters of lipid profile and estimated glomerular filtratio...
Hypertriglyceridemia in patients with chronic renal failure: Possible mechanisms. Cardiovascular dis...
Background. Recent research has clarified the relationship between adipokines, metabolic syndrome (M...
Patients with chronic renal impairment (CRI) are at greatly increased risk for premature vascular di...
Chronic kidney disease (CKD) patients are at an increased risk of cardiovascular complications and p...
Patients with chronic renal impairment (CRI) are at greatly increased risk for premature vascular di...
Leptin (LPT) is associated with a number of cardiovascular risk factors, such as high blood pressure...
The evolution of cardiovascular diseases among patients with chronic kidney disease (CKD) not requir...
Cardiovascular risk factors in pre-dialysis patients: Baseline data from the Chronic Renal Impairmen...
Objective: Previous studies investigating associations between serum lipids and renal disease have g...
Dyslipidemia plays an essential role in chronic kidney disease (CKD). The role of lipids and lipopro...
Kidney dysfunction increases cardiovascular disease (CVD) risk. The mechanisms for the risk increase...
Background and aims. Dyslipidemia (DLP) is a common complication of chronic kidney disease (CKD) and...
Plasma lipids and risk of developing renal dysfunction: The Atherosclerosis Risk in Communities Stud...
Background. Generalized atherosclerosis is increasingly recognized as an important cause of end-stag...
Aim To investigate the association of parameters of lipid profile and estimated glomerular filtratio...
Hypertriglyceridemia in patients with chronic renal failure: Possible mechanisms. Cardiovascular dis...
Background. Recent research has clarified the relationship between adipokines, metabolic syndrome (M...
Patients with chronic renal impairment (CRI) are at greatly increased risk for premature vascular di...
Chronic kidney disease (CKD) patients are at an increased risk of cardiovascular complications and p...
Patients with chronic renal impairment (CRI) are at greatly increased risk for premature vascular di...
Leptin (LPT) is associated with a number of cardiovascular risk factors, such as high blood pressure...
The evolution of cardiovascular diseases among patients with chronic kidney disease (CKD) not requir...
Cardiovascular risk factors in pre-dialysis patients: Baseline data from the Chronic Renal Impairmen...
Objective: Previous studies investigating associations between serum lipids and renal disease have g...
Dyslipidemia plays an essential role in chronic kidney disease (CKD). The role of lipids and lipopro...
Kidney dysfunction increases cardiovascular disease (CVD) risk. The mechanisms for the risk increase...
Background and aims. Dyslipidemia (DLP) is a common complication of chronic kidney disease (CKD) and...
Plasma lipids and risk of developing renal dysfunction: The Atherosclerosis Risk in Communities Stud...
Background. Generalized atherosclerosis is increasingly recognized as an important cause of end-stag...
Aim To investigate the association of parameters of lipid profile and estimated glomerular filtratio...
Hypertriglyceridemia in patients with chronic renal failure: Possible mechanisms. Cardiovascular dis...
Background. Recent research has clarified the relationship between adipokines, metabolic syndrome (M...